Intelligent Bio Solutions (INBS) Receivables (2021 - 2025)

Intelligent Bio Solutions' Receivables history runs 5 years deep, the most recent figure standing at $1.3 million for Q2 2025.

• In Q2 2025, Receivables rose 200.16% year-over-year to $1.3 million; the TTM figure through Jun 2025 stood at $1.3 million (up 200.16% YoY), while the FY2025 annual figure was $1.3 million, up 200.16% from the prior year.
• Receivables was $1.3 million for Q2 2025 at Intelligent Bio Solutions, up from $1.0 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $3.0 million in Q1 2022 to a low of $442777.0 in Q2 2024.
• Historically, Receivables has averaged $1.4 million across 5 years, with a median of $1.1 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Receivables slumped 79.27% in 2023, then soared 200.16% in 2025.
• A 5-year view of Receivables shows it stood at $2.8 million in 2021, then slipped by 5.83% to $2.7 million in 2022, then plunged by 79.27% to $552001.0 in 2023, then increased by 16.26% to $641767.0 in 2024, then surged by 107.09% to $1.3 million in 2025.
• The last three Receivables figures came in at $1.3 million (Q2 2025), $1.0 million (Q1 2025), and $641767.0 (Q4 2024), per Business Quant data.